Home > Income Statement > WANBURY

WANBURY
Revenue

    Back to Income Statement
WANBURY is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹600 Cr₹578 Cr₹500 Cr₹511 Cr₹393 Cr

What is the latest Revenue of WANBURY ?

The latest Revenue ratio of WANBURY is ₹600 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹600 Cr
Mar2024₹578 Cr
Mar2023₹500 Cr
Mar2022₹511 Cr
Mar2021₹393 Cr

How is Revenue of WANBURY Trending?

Years Revenue % Change
Mar2025 ₹600 Cr
3.77
Mar2024 ₹578 Cr
15.63
Mar2023 ₹500 Cr
-2.26
Mar2022 ₹511 Cr
30.23
Mar2021 ₹393 Cr -

Compare Revenue of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹872.7 Cr -6.1% -3% 45.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,628.0 Cr 3.5% 5.6% 11.9% Stock Analytics
DIVIS LABORATORIES ₹167,975.0 Cr -1.3% 4.5% 16.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,804.0 Cr -0.7% 6.9% 47.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,829.0 Cr 1.3% 5.1% 17.5% Stock Analytics
CIPLA ₹106,768.0 Cr -1.9% -0.3% -6% Stock Analytics


WANBURY Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

-6.1%

-3%

45.5%

SENSEX

-4.1%

-5.8%

5.8%


You may also like the below Video Courses